Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 1,244 shares at $180.73 ($225K) on 2018-03-12, disclosed to the SEC on 2018-03-13.
Open-market sale of $225k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.73 | 622 | $112K | 50.0% |
| 2 | $180.73 | 622 | $112K | 50.0% |
| Total | $180.73 avg | 1,244 | $225K | 100% |
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |